Skip to search formSkip to main contentSkip to account menu

Vigamox

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

moxifloxacin
moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox]moxifloxacin Ophthalmic Solution [Vigamox]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Prophylaxis of Postoperative Acute Endopthalmitis Following Cataract Surgery
Background: Postoperative Endophthalmitis is a rare complication after intraocular surgeries. However, it remains one of the most… 
2013
2013
Comparison of Prophylactic Options for Post- Operative Endophthalmitis after Cataract Extraction with Intra Ocular Lens Implantation
Background: To compare prophylactic use of intracameral Moxifloxacin (Vigamox) with subconjuctival injection of Ceftriaxone and… 
2012
2012
Comparative Pathological Studies on the Healing Effect of Natural (Terfezia claveryi) and Synthetic (Vigamox) Antimicrobials on Corneal Ulcers in Rabbits
This study aimed to evaluate the role of Terfezia claveryi crude extract in the healing of induced corneal ulcers in rabbits in… 
2009
2009
Moxifloxacin intrakameral: Eine sichere Option zur Endophthalmitisprophylaxe?
ZusammenfassungHintergrundDie Wirksamkeit von Moxifloxacin (Vigamox®) umfasst die meisten für bakterielle Endophthalmitiden… 
2008
2008
Intracameral moxifloxacin (Vigamox): in vitro safety on human ocular cells
Purpose The 4. generation fluorochinolon moxifloxacin covers most isolates causing endophthalmitis. It is safe and effective for… 
Review
2006
Review
2006
Integrating Iquix, Vigamox, and Zymar in the Management of Ocular Infectious Disease
Familiarity with the therapeutic characteristics of antibiotics available for use in ophthalmology is essential for all… 
2006
2006
Confocal Assessment of the Effects of Fourth-Generation Fluoroquinolones on the Cornea
Purpose. To evaluate the toxicity of fourth-generation fluoroquinolone antibiotic solutions on the rabbit corneal epithelium… 
2006
2006
Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model.
2006
2006
A Ten–Week Toxicity Evaluation of VIGAMOX (0.5% moxifloxacin solution) Following a Single Intravitreal Injection in Nonhuman Primates
Highly Cited
2005
Highly Cited
2005
Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)